pfizer oral glp 1 selects new drug for danuglipron | Pharmaceutical Business Review International posted on the topic PDB-101: Molecule of the Month:

Our analysis indicates that between 20 and 30 percent of annual patients stop using the drugs, particularly those focused on weight loss, and these patients regain about two-thirds of the weight they lost

There is no link between GLP-1 use and positive results on employment or legal drug tests

If your goals are related to improving exercise performance and recovery you may want to utilize L-carnitine L-tartrate

To match your unique physiology and treatment goals, your formulation may also include supportive ingredients like Cyanocobalamin (Vitamin B12)

GLP-1 medications require a valid prescription from a licensed clinician.